tradingkey.logo

Gelteq Ltd

GELS
1.070USD
-0.020-1.83%
Horário de mercado ETCotações atrasadas em 15 min
10.33MValor de mercado
PerdaP/L TTM

Mais detalhes de Gelteq Ltd Empresa

Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Informações de Gelteq Ltd

Código da empresaGELS
Nome da EmpresaGelteq Ltd
Data de listagemOct 29, 2024
CEOMr. Nathan Jacob Givoni
Número de funcionários7
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 29
EndereçoLevel 4
CidadeMELBOURNE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísAustralia
Código postal3205
Telefone61390873990
Sitehttps://www.gelteq.com
Código da empresaGELS
Data de listagemOct 29, 2024
CEOMr. Nathan Jacob Givoni

Executivos da empresa Gelteq Ltd

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Sem dados
Sem dados
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Markoff (Jeffrey)
24.34%
Golik (David)
10.09%
Givoni (Nathan Jacob)
6.55%
Crestmont Pty Ltd
6.41%
Barabash Family Trust
4.40%
Outro
48.21%
Investidores
Investidores
Proporção
Markoff (Jeffrey)
24.34%
Golik (David)
10.09%
Givoni (Nathan Jacob)
6.55%
Crestmont Pty Ltd
6.41%
Barabash Family Trust
4.40%
Outro
48.21%
Tipos de investidores
Investidores
Proporção
Individual Investor
46.00%
Corporation
10.80%
Investment Advisor
0.50%
Research Firm
0.32%
Hedge Fund
0.23%
Outro
42.14%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
8
105.80K
1.05%
+654.00
2025Q2
15
5.77M
61.13%
-9.31K
2025Q1
15
5.80M
61.47%
+24.19K
2024Q4
13
5.78M
61.21%
+80.95K

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Markoff (Jeffrey)
2.44M
24.34%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.09%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.55%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.41%
--
--
Nov 15, 2024
Barabash Family Trust
441.00K
4.4%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.37%
--
--
Nov 15, 2024
Olyniec (Jeffrey W.)
164.81K
1.64%
--
--
Nov 15, 2024
HRT Financial LP
44.62K
0.44%
+44.62K
--
Jun 30, 2025
Citadel Advisors LLC
23.20K
0.23%
+8.04K
+52.99%
Jun 30, 2025
Wedbush Securities, Inc.
20.00K
0.2%
-32.25K
-61.72%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI